Global News

CluePoints hires Borders and Estrella

Tuesday, December 12, 2017

CluePoints, a provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has announced two new strategic appointments to strengthen its business development team. Nick Borders and Rob Estrella join the CluePoints U.S. team to support its impressive global business growth, allowing the company to increase its expanding client base across North America.

[Read More]

Certara introduces New Investigator Awards program in Australia

Monday, December 11, 2017

Certara, a global leader in model-informed drug development and regulatory science, announced that Leigh Farrell, PhD, Vice President of Corporate Strategy and Business Development, is presenting the inaugural Certara New Investigator Awards in association with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). The presentation will take place today at the Australasian Pharmaceutical Science Association (APSA) and ASCEPT Joint Scientific Meeting at the Brisbane Convention & Exhibition Centre. These new Certara awards recognize graduate investigators that are excelling in clinical and experimental pharmacology and toxicology.

[Read More]

Zilliqa and Global Brain Blockchain Labs partner

Monday, December 11, 2017

Zilliqa, a highly anticipated blockchain platform based on the technology of sharding, has announced a partnership with GB Blockchain Labs (GBBL), the blockchain arm of Global Brain, one of the largest VC firms in Japan. Zilliqa will also be part of the Global Brain Alliance Forum 2017 to be held in Tokyo on December 8.

[Read More]

NIH’s All of Us Research Program, NLM collaborate on outreach efforts through libraries

Monday, December 11, 2017

NIH’s All of Us Research Program and the National Library of Medicine (NLM) have teamed up in a landmark effort to advance precision medicine for the benefit of communities through local libraries. Traditional healthcare takes a “one-size fits all” approach, but precision medicine is healthcare that is “tailored to a person based on things unique to that individual, such as their lifestyle, environment and their biology,” said Dara Richardson-Heron, M.D., chief engagement officer, NIH’s All of Us Research Program. 

[Read More]

Health disparities and clinical trial patient recruitment

Monday, December 11, 2017

The Pulse on Patient Recruitment by Ashley Tointon

Despite remarkable improvements in the number of people with healthcare coverage and the vast improvements in many healthcare technologies, not everyone in the nation has benefited equally. Individuals who are low-income, a racial/ethnic minority or who are disadvantaged or disabled typically do not get involved in cutting-edge medical research. 

[Read More]